Transseptal Solutions Announces First Clinical Use of TSP Crosser in the United States
June 12, 2019—Transseptal Solutions Ltd., an Israel-based developer of the TSP Crosser, which provides transseptal puncture and left atrial navigation in a single device, announced that the first transseptal puncture procedure in the United States was successfully performed by Azeem Latib, MD, in a patient undergoing percutaneous balloon mitral valvuloplasty. The TSP Crosser has FDA clearance in the United States and CE Mark approval in Europe.
Dr. Latib is Medical Director of Structural Heart Interventions and Heart Valve Program at Montefiore-Einstein Center for Heart and Vascular Care in New York, New York. He commented in the company's announcement, “The TSP Crosser is an innovative device that facilitates safe, accurate, and reproducible transseptal puncture. We are honored at Montefiore to be the first United States center to be utilizing this device that will be will benefit both novice and expert structural heart operators."
According to the company, the TSP Crosser transseptal puncture system is designed to provide accurate, quick, and safe access to the left atrium. The device, which features a built-in steering mechanism, is indicated for use in procedures where access to the left atrium via transseptal technique is desired, such as mitral valve repair, mitral valve replacement, paravalvular leak closure, left atrial appendage closure, and electrophysiology ablation treatments.
The TSP Crosser transseptal access system combines a sheath, dilator, and a flexible puncturing needle in a single integrated system for controlled left atrial access and enhanced performance during transseptal catheterization procedures. A radiopaque loop wire is positioned at the distal end of the steerable sheath to aid in the localization of the fossa ovalis. The flexible puncturing needle and the steerable sheath allows prepuncture deflection and orientation, positioning the needle in the desired puncturing location of the fossa ovalis for transseptal access. The sheath is steerable up to 180° bidirectionally after crossing the fossa ovalis, noted the company.
advertisement
Featured Video
Conquer the Calcium.
Deliver the Stent.
Sponsored by Cardiovascular Systems Inc.
Related Articles
Top 5 Articles From June 2019
Transseptal Puncture: A Step-by-Step Procedural Guide
Knowledge of interatrial septum anatomy, appropriate equipment, and proper technique are key to successful transseptal puncture.
By Giulio Russo, MD; Maurizio Taramasso, MD, PhD; and Francesco Maisano, MD
Roundtable Discussion: Real-World Challenges in the Structural Imaging Arena
Edwin C. Ho, MD, FRCPC, engages an expert panel on issues important to navigating a career in structural heart interventional imaging.
With Andrew D. Choi, MD, FACC, FSCCT; Jeffrey B. Geske, MD, FACC, FASE; Stephen H. Little, MD, FRCPC, FACC, FASE; and Dee Dee Wang, MD, FACC, FASE, FSCCT
FFRCT: Why Should Interventional Cardiologists Care?
Is FFRCT the holy grail of combined noninvasive coronary anatomic and physiologic evaluation?
By Omar Khalique, MD, FACC, FASE, FSCCT, FSCMR
Early Returns for Groups Participating in Medicare’s BPCI Advanced Program
A review of refinements to the BPCI-A program, insights gained from enrolled groups, and attributes of high-performing participants, with a specific focus on the PCI bundles.
By Keely Macmillan; and Joel Sauer, MBA
Angiography-Based FFR: Reevaluating the Role of the Pressure Wire
Reviewing the nuances of coronary angiography–based FFR and results of initial validation studies.
By Kaneshka Masdjedi, MD; and Joost Daemen, MD, PhD
Top 5 from EVToday's Current Issue
What’s New in Y-90?
Technical and procedural innovations in Y-90 radioembolization including existing and investigational next-generation technologies.
By Robert Abraham, MD, FRCPC, FSIR; Robert Lewandowski, MD, FSIR; Ripal T. Gandhi, MD, FSIR, FSVM; and David M. Liu, MD, FRCPC, FSIR
Transradial Access for Hepatic Oncologic Interventions
Considerations for choosing the right access equipment.
By Darren Klass, MBChB, MD, MRCS, FCRC, FRCPC; Anastasia Hadjivassiliou, MBBS, FRCR, FRCPC; and John Chung, MD, FRCPC
Is It Time to End the Therapeutic Nihilism Toward Treating VTE in Cancer Patients?
Cases highlighting the potential for early benefit and improved quality of life and function associated with the use of FlowTriever and ClotTriever Systems in patients with cancer and VTE.
With Sirish A. Kishore, MD; and William C. Dillon, MD, FACC
Contemporary Management of Pancreatic Cancer
An update on state-of-the-art minimally invasive therapies, including recent advances in surgery, radiation therapy, ablative options, and endovascular therapies.
By Ripal T. Gandhi, MD, FSIR, FSVM; Horacio Asbun, MD; Michael Chuong, MD; Filipe Kunzler, MD; and Govindarajan Narayanan, MD
Top Tips in Interventional Oncology
Clinical and technical insights into treating hepatocellular carcinoma, cholangiocarcinoma, renal cell carcinoma, lung cancer, bone cancer, and in the palliative care setting.
